SAIL
Live / Allowed — Notice of allowance issued (as of 02 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Dec 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98297806
- Mark type
- Stylized text
- Filed
- 04 Dec 2023
- Published for opposition
- 05 Nov 2024
- Attorney of record
- CHRISTINA M. LICURSI
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; none of the foregoing for the treatment of pyruvate dehydrogenase complex deficiency (PDCD), osteoarthritis, or limb spasticity
- Class 042 — Scientific and technological services: Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals; none of the foregoing related to the treatment of pyruvate dehydrogenase complex deficiency (PDCD), osteoarthritis, or limb spasticity
Owner
- Sail Biomedicines, Inc., Somerville, MA, US
- Sail Biomedicines, Inc., Somerville, MA, US
Prosecution history
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 21 Oct 2025 — OPPOSITION TERMINATED NO. 999999
- 21 Oct 2025 — OPPOSITION DISMISSED NO. 999999
- 04 Dec 2024 — OPPOSITION INSTITUTED NO. 999999
- 04 Dec 2024 — OPPOSITION PAPERS RECEIVED AT TTAB
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Jul 2024 — NON-FINAL ACTION E-MAILED